PEAK6’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.23M Buy
16,100
+14,700
+1,050% +$5.45M 0.01% 762
2026
Q1
$410K Sell
1,400
-35,200
-96% -$11.6M ﹤0.01% 2063
2025
Q4
$12.8M Sell
36,600
-8,600
-19% -$2.91M 0.02% 534
2025
Q3
$14.6M Buy
45,200
+15,400
+52% +$4.79M 0.02% 532
2025
Q2
$11.6M Buy
29,800
+29,200
+4,867% +$11.7M 0.02% 574
2025
Q1
$261K Sell
600
-6,000
-91% -$2.41M ﹤0.01% 2338
2024
Q4
$2.43M Buy
+6,600
New +$2.76M 0.01% 1309

Other funds holding ELV

PEAK6's ELV Position: Q2 2026 in Review

PEAK6 opened a new position in Elevance Health (ELV) in Q2 2026: 888 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings. This is a return to the name: PEAK6 previously reported a position in ELV as recently as Q4 2025.

PEAK6 first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.8M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PEAK6 held 888 shares of Elevance Health worth $343K as of Q2 2026.
  • Elevance Health was a new PEAK6 position in Q2 2026.
  • Elevance Health made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2106 holding.
  • PEAK6 first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Elevance Health position peaked at $10.8M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.